Rescinnamine in treatment of hypertension in hospital clinic and in general practice.
作者信息
FIFE R, MACLAURIN J C, WRIGHT J H
出版信息
Br Med J. 1960 Dec 24;2(5216):1848-50. doi: 10.1136/bmj.2.5216.1848.
Abstract
摘要
相似文献
1
Rescinnamine in treatment of hypertension in hospital clinic and in general practice.利血胺在医院门诊和普通医疗中治疗高血压的应用。
Br Med J. 1960 Dec 24;2(5216):1848-50. doi: 10.1136/bmj.2.5216.1848.
2
[Action of rescinnamine, Rauwolfia serpentina alkdloid, on renal hemodynamics in patients with arterial hypertension].[萝芙木生物碱利血胺对动脉高血压患者肾血流动力学的作用]
Rass Int Clin Ter. 1961 Jan 31;41:51-8.
3
Clinical trial of methoserpidine in general practice.美索舍平在全科医疗中的临床试验。
Br Med J. 1961 Dec 30;2(5269):1738-41. doi: 10.1136/bmj.2.5269.1738.
4
An evaluation of combined benzthiazide and rescinnamine therapy in arterial hypertension.苄噻嗪与利血胺联合治疗动脉高血压的评估
J Am Geriatr Soc. 1961 Feb;9:144-51. doi: 10.1111/j.1532-5415.1961.tb02508.x.
5
Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.用从蛇根木中分离出的一种新生物碱萝芙辛治疗动脉高血压。
Can Med Assoc J. 1956 Jan 15;74(2):144-5.
6
7
[Therapeutic trials of 10-methoxy-deserpidine in the treatment of arterial hypertension].10-甲氧基-利血平治疗动脉高血压的治疗试验
Lyon Med. 1959 Nov 15;91:843-70.
8
[Therapeutic trials of a methoserpidine-benzthiazide combination in arterial hypertension].[美索舍平-苄噻嗪联合用药治疗动脉高血压的试验]
Lyon Med. 1962 Jun 3;94:1427-55.
9
A combination of methyclothiazide and deserpidine in the treatment of essential hypertension.甲基氯噻嗪与地舍平联合治疗原发性高血压。
Dis Chest. 1962 Aug;42:170-5. doi: 10.1378/chest.42.2.170.
10
Clinical study of deserpidine-methamphetamine-pentobarbital combination in hypertension.去甲氧基利血平-甲基苯丙胺-戊巴比妥联合用药治疗高血压的临床研究
Clin Med (Northfield). 1962 Jan;69:112-6.
引用本文的文献
1
Current Status of Indole-Derived Marine Natural Products: Synthetic Approaches and Therapeutic Applications.吲哚衍生海洋天然产物的研究现状：合成方法与治疗应用。
Mar Drugs. 2024 Mar 6;22(3):126. doi: 10.3390/md22030126.
2
Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.3,4,5-三甲氧基肉桂酸（TMCA）衍生物的生物活性研究进展。
Eur J Med Chem. 2019 Jul 1;173:213-227. doi: 10.1016/j.ejmech.2019.04.009. Epub 2019 Apr 6.
3
4
Clinical trial of methoserpidine in general practice.美索舍平在全科医疗中的临床试验。
Br Med J. 1961 Dec 30;2(5269):1738-41. doi: 10.1136/bmj.2.5269.1738.
本文引用的文献
1
Comparison of rescinnamine and reserpine as hypotensive agents.利血胺与利血平作为降压药的比较。
Lancet. 1955 Jul 16;269(6881):115-6. doi: 10.1016/s0140-6736(55)92116-4.
2
Diagnosis and treatment of essential hypertension.原发性高血压的诊断与治疗。
Lancet. 1959 May 9;1(7080):953-8 concl. doi: 10.1016/s0140-6736(59)91076-1.
3
The out-patient department and the general practitioner.
R Soc Health J. 1958 Jul-Aug;78(4):460-4. doi: 10.1177/146642405807800434.
4
Treatment of hypertension in out-patients; the initial assessment, and the effect of reserpine.门诊高血压治疗；初始评估及利血平的疗效
Scott Med J. 1958 Apr;3(4):165-72. doi: 10.1177/003693305800300402.
5
Therapeutic value and limitations of an ataractic drug (rescinnamine).一种镇静药物（利血胺）的治疗价值及局限性
Int Rec Med Gen Pract Clin. 1957 Dec;170(12):665-71.
6
The response to rescinnamine administered parenterally and orally for the treatment of hypertension.肠胃外和口服利血胺治疗高血压的反应。
Am J Med Sci. 1956 May;231(5):542-57. doi: 10.1097/00000441-195605000-00007.
7
Treatment of arterial hypertension with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.用从蛇根木中分离出的一种新生物碱萝芙辛治疗动脉高血压。
Can Med Assoc J. 1956 Jan 15;74(2):144-5.
8
Drug therapy (Rauwolfia) of hypertension. II. A comparative study of different extracts of Rauwolfia when each is used alone (orally) for therapy of ambulatory patients with hypertension.高血压的药物治疗（萝芙木）。II. 萝芙木不同提取物单独（口服）用于门诊高血压患者治疗的比较研究。
AMA Arch Intern Med. 1955 Oct;96(4):530-43. doi: 10.1001/archinte.1955.00250150104011.
9
Pharmacological studies with rescinnamine, a new alkaloid isolated from Rauwolfia serpentina.对从蛇根木中分离出的一种新生物碱萝芙辛碱的药理学研究。
Proc Soc Exp Biol Med. 1954 May;86(1):120-4. doi: 10.3181/00379727-86-21027.
10
The threshold of age.年龄的门槛。
Lancet. 1954 May 15;266(6820):991-4. doi: 10.1016/s0140-6736(54)92394-6.
Zotero 插件